A New Mechanism Involving ERK Contributes to Rosiglitazone Inhibition of Tumor Necrosis Factor-α and Interferon-γ Inflammatory Effects in Human Endothelial Cells
2008 ◽
Vol 28
(4)
◽
pp. 718-724
◽
2005 ◽
Vol 280
(35)
◽
pp. 31076-31084
◽
1993 ◽
Vol 63
(3)
◽
pp. 327-334
◽
2003 ◽
Vol 121
(5)
◽
pp. 1191-1196
◽
2000 ◽
Vol 20
(2)
◽
pp. 410-415
◽
2010 ◽
Vol 21
(2)
◽
pp. 116-124
◽
1994 ◽
Vol 160
(2)
◽
pp. 367-377
◽